Login | Register

Parkinson’s Disease Vaccine Human Trial

The first human trial on the cause of Parkinson's disease vaccine has begun. Called PD01A, the vaccine targets a protein - alpha-Synuclein - which experts say causes the onset and development of the disease. The Phase I trial is being conducted by AFFiRiS AG, an Austrian pharmaceutical company. The company hopes the vaccine may deliver a causative treatment for Parkinson's...

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *